1
Eliezer Flescher, Orit Fingrut: Jasmonate pharmaceutical composition for treatment of cancer. Ramot University Authority for Applied Research and Industrial Development, Lowe Hauptman Gilman & Berner, October 22, 2002: US06469061 (23 worldwide citation)

A pharmaceutical composition useful for the treatment of cancer in mamnmals, comprising as the active ingredient a therapeutically effective amount of a jasmonate of the formula:


2
Engstad Rolf Einar: Therapy-enhancing glucan. Sloan Kettering Institute For Cancer Research, Biotec Pharmacon Asa, Engstad Rolf Einar, CHAN Albert Wai Kit, July 26, 2007: WO/2007/084661 (8 worldwide citation)

A therapeutic composition for treatment of cancer in a mammal is disclosed. The composition comprises an effective amount of a yeast beta-glucan composition which is suitable for oral administration and for absorption through the gastrointestinal tract of the mammal. The above therapeutic compositio ...


3

4

5
Rajko D Medenica: Use of nigella sativa to increase immune function. DeWitt Ross & Stevens SC, August 5, 1997: US05653981 (3 worldwide citation)

A pharmaceutical composition for treatment of cancer and other conditions and the prevention of side effects of anticancer chemotherapy and increasing the immune function contains an extract of the plant Nigella sativa.


6
Nai Kong V Cheung, Rolf Einar Engstad: Therapy-enhancing glucan. Sloan Kettering Institute for Cancer Research, Biotec Pharmacon ASA, Law Offices of Albert Wai Kit Chan PLLC, December 4, 2012: US08323644 (2 worldwide citation)

A therapeutic composition for treatment of cancer in a mammal is disclosed. The composition comprises an effective amount of a yeast beta-glucan composition which is suitable for oral administration and for absorption through the gastrointestinal tract of the mammal. The above therapeutic compositio ...


7
Cen Lan Bo, Shishido Tadao: Compositon containing rhodacyanine dyes for treating cancer.. Fuji Photo Film, Dana Farber Cancer Inst, February 17, 1993: EP0527494-A1 (2 worldwide citation)

A pharmaceutical composition for treatment of cancer comprises: (A) a therapeutically effective amount of at least one compound selected from the group consisting of compounds represented by the General Formula (I) wherein X1 and X2, which may be the same or different, each represents O, S, Se, -CH= ...


8
Noriaki Tatsuta, Akihiko Okegawa, Masayuki Kawakami, Keizo Koya: Water-soluble methine compound and pharmaceutical composition for treatment of cancer comprising the same. Fuji Photo Film, Sughrue Mion Zinn Macpeak & Seas, February 4, 1997: US05599825 (2 worldwide citation)

There are provided methine compounds having the following structure and their analogs, with a high solubility and are usefull as an active ingredient for pharmaceutical composition for treatment of cancer: ##STR1##


9
Weng Guoying, Zhou Wei, Cheng Guang, Cheng Peiyuan: Paclitaxel liposome composition for treatment of cancer and preparation thereof. Nanjing Zhenzhong Bioengineeri, August 6, 2003: EP1332755-A1 (2 worldwide citation)

The present invention relates to a paclitaxel-based liposome composition for treatment of cancer, which consists substantially of the following materials by weight: paclitaxel 2-5 parts, phosphatide 20-200 parts, cholesterol 2-30 parts, amino acids 0.3-4 parts, and lyophilized excipient 10-75 parts. ...


10
Aleksov Julian, Lokot Igor: Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance. Ardenia Investments, Aleksov Julian, Lokot Igor, BERGENSTRÃ…HLE Per Bjerndell Box 17704 S 118 93 Stockholm, June 25, 2009: WO/2009/078803 (2 worldwide citation)

A drug delivery system (DDS) for administration of a water soluble, cationic, and amphiphilic pharmaceutically active substance (API) which DDS comprises poorly water soluble nanoparticles formed by the API together with a Na-salt of N-all- trans-retinoyl cysteic acid methyl ester and/or a Na-salt o ...